Mr Colin Sainsbury > ByrneWallace LLP > Dublin, Ireland > Lawyer Profile

The ‘first-class‘ team at ByrneWallace LLP has continued to expand its client base, adding a number of foreign investors to an impressive roster of pharmaceutical and medical device companies and public bodies. Colin Sainsbury heads the life sciences practice, which has expertise in M&A, fundraisings, licensing and regulatory issues. The health and social care team, which is experienced in litigation, governance and regulation, is led by Sinéad Kearney and also includes mental health law specialist Olive Doyle. Catherine Dowling and senior associate Laura Greene, who has expertise in advising international clients on Irish regulation, are also recommended.

ByrneWallace LLP stands out in the market for its work in the life sciences sector, where it advises on the IP aspects of corporate transactions, the commercialisation of IP rights, and the spin outs of life sciences companies from universities. The team also advises on IP registration and infringement in areas including media, academia and technology. The team is led by Colin Sainsbury (who also leads the firm’s life sciences team), Darren Daly and Jon Legorburu.

The ‘very strong‘ team at ByrneWallace LLP is particularly well known for its expertise in corporate transactions in the life sciences space. In addition, it is also highly active in the technology, renewable energy and public sectors. The team has a busy M&A practice and also regularly advises both funds and investees on private equity transactions. Its diverse client base also includes start-up companies, large corporates and public sector bodies. The ‘standout‘ Neil Keenan leads the team, which also includes Gerry Beausang and life sciences specialists Colin Sainsbury and Catherine Dowling.